Show simple item record

Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Final Results From the Phase 3 U-ACHIEVE Maintenance Study

dc.contributor.authorVermeire, Sen_US
dc.contributor.authorDanese, Sen_US
dc.contributor.authorZhou, Wen_US
dc.contributor.authorYao, Xen_US
dc.contributor.authorIlo, Den_US
dc.contributor.authorLiu, Jen_US
dc.contributor.authorHebuterne, Xen_US
dc.contributor.authorLindsay, Jen_US
dc.contributor.authorSanchez-Gonzalez, Yen_US
dc.contributor.authorHiggins, PDen_US
dc.contributor.authorColombel, J-Fen_US
dc.contributor.authorPanaccione, Ren_US
dc.date.accessioned2024-03-11T09:07:25Z
dc.date.issued2022en_US
dc.identifier.issn0002-9270en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/95167
dc.format.extentS521 - S522en_US
dc.titleEfficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Final Results From the Phase 3 U-ACHIEVE Maintenance Studyen_US
dc.typeConference Proceeding
dc.rights.holder© 2022 by The American College of Gastroenterology
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000897916001335&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue10en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume117en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record